{"date":"2025-10-10","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6838-2025-10-10-0019-lnj9s3","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-10-10","time":"00:19:57","subject":"公告本公司初次申請股票上市時所出具之承諾事項執行情形","clause":"第51款","fact_date":"2025-10-10","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-10-10 00:19，「公告本公司初次申請股票上市時所出具之承諾事項執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}